Although SJS/TEN is an extremely rare AE associated with any medication including EGFR-TKIs, it requires close attention considering its rapid progression and the possibility of severe ocular, cutaneous and renal complications, which may impair patients’ quality of life. The gene discussed is EGFR; the disease is toxic epidermal necrolysis.